Vis enkel innførsel

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies

dc.contributor.authorLi, Ling
dc.contributor.authorLi, Sheyu
dc.contributor.authorDeng, Ke
dc.contributor.authorLiu, Jiali
dc.contributor.authorVandvik, Per Olav
dc.contributor.authorZhao, Pujing
dc.contributor.authorZhang, Longhao
dc.contributor.authorShen, Jiantong
dc.contributor.authorBala, Malgorzata M.
dc.contributor.authorSohani, Zahra N.
dc.contributor.authorWong, Evelyn
dc.contributor.authorBusse, Jason Walter
dc.contributor.authorEbrahim, Shanil
dc.contributor.authorMalaga, German
dc.contributor.authorRios, Lorena P.
dc.contributor.authorWang, Yingqiang
dc.contributor.authorChen, Qunfei
dc.contributor.authorGuyatt, Gordon Henry
dc.contributor.authorSun, Xin
dc.date.accessioned2017-02-22T12:32:02Z
dc.date.available2017-02-22T12:32:02Z
dc.date.created2016-06-27T10:37:16Z
dc.date.issued2016
dc.identifier.citationBMJ (British Medical Journal). 2016, 352 .
dc.identifier.issn0959-8146
dc.identifier.urihttp://hdl.handle.net/11250/2431768
dc.language.isoeng
dc.relation.urihttp://www.bmj.com/content/352/bmj.i610
dc.titleDipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies
dc.typePeer reviewed
dc.typeJournal article
dc.source.pagenumber17
dc.source.volume352
dc.source.journalBMJ (British Medical Journal)
dc.identifier.doi10.1136/bmj.i610
dc.identifier.cristin1364394
cristin.unitcode7502,7,2,2
cristin.unitnameForebyggende, helsefremmende og organisatoriske tiltak
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail
Filnavn:
Li_2016_Dip.pdf
Størrelse:
712.5Kb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel